PRZOOM - /newswire/ -
Delhi, New Delhi, India, 2008/06/20 - The E7 pharmaceutical markets are expected to grow at a CAGR of 11.5% by 2012 due to strong economic growth, improving medical infrastructure and rising retail pharmacies.
A new market research report, “Emerging Pharmaceutical Markets Globally”, recently released by RNCOS says that the pharmaceutical markets in E7 countries are anticipated to grow at a CAGR of 11.5% from 2008 to 2012. This growth rate is more than double of that in G7 markets.
The report identifies that strong economic growth in E7 countries is one of the main reasons driving growth in their pharmaceutical markets. The total disposable income of the E7 countries is anticipated to grow two-fold in 2012 against US$ 4.4 Trillion in 2007, which will increase the expenditure on healthcare and drugs in the region.
Furthermore, the medical infrastructure has developed tremendously in the E7 countries in the last decade, says the report. As a result, a large number of clinics and hospitals have opened in these countries. With opening of new clinics and hospitals, patients are increasingly taking professional advice from physicians instead of following self-medication and conventional therapies. As the sales of pharmaceutical sector are directly linked to physician visits, a rise in physician visits has augmented the sales.
Besides, the report says that an improvement in the medical infrastructure has directly impacted the smaller towns and villages where majority of E7 countries’ population resides. The volume of retail pharmaceutical stores in small towns and villages has substantially expanded in the last decade, providing quality and affordable drugs in these areas.
“Emerging Pharmaceutical Markets Globally” is a comprehensive report providing data on emerging pharmaceutical markets worldwide. It highlights the difference between developed and emerging markets in terms of traditional therapies, health and insurance scenario, and intellectual property, giving critical information to pharmaceutical companies and investors planning to enter these markets to help them make strategies according to the E7 markets. The report also gives forecast on generic drugs and domestic pharmaceutical markets by region and country.
RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of industry experts who analyze data collected from credible sources. They provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.